small molecule

ASACOL HD

MESALAMINE

Loss of exclusivityloss of exclusivity
CompanyAbbVie Inc.See this company's full patent-cliff portfolio

Drug detail

Brand nameASACOL HD
Active ingredientMESALAMINE
Strength800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2008
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ASACOL HD patent cliff — loss of exclusivity — | CliffBio